Medtronic Minimally Invasive Therapies will launch its SolitaireFR revascularization device for acute ischemic strokes in the U.S. next month following receipt of 510(k) clearance, the firm announced March 5.
The FDA clearance comes several weeks earlier than expected. During the firm’s Jan. 26 first-quarter earnings call, the device maker forecasted clearance in April or May. The device debuted overseas...